| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a979886a32009bc20f8774e28abff648
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66f7a12a5a5eba2bb879cd5588e75406 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 |
| filingDate |
2003-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cb49c09cc15282a18cb286a0d805f7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a21dcb0e5dcae7a46b750383d23dbac0 |
| publicationDate |
2003-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03080057-A1 |
| titleOfInvention |
Downsized core tablet containing nifedipine |
| abstract |
A downsized core tablet containing nifedipine to be administered once a day which is obtained by, in the core comprising nifedipine and a hydrophilic gel-forming polymer, reducing the amount of the hydrophilic gel-forming polymer and adding a disintegration inhibitor thereto to thereby downsize the core without affecting the elution of nifedipine, and then compression-coating the core with a shell comprising nifedipine, a hydrophilic gel-forming polymer and a disintegration inhibitor. A combined drug containing nifedipine together with a second drug component wherein at least a part of the above tablet is compression-coated with a quick-release formulation containing the second drug component. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9539176-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010060564-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9993432-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007001067-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102008059206-A1 |
| priorityDate |
2002-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |